PidPort is a pathology image management cloud system that can be used as an optimal repository for digital pathological specimens. Multiple healthcare professionals can view and share cloud-stored pathological specimens anytime and anywhere. It can be utilized for a wide range of purposes such as remote consultations, academic meetings, conferences, and educational lectures across facilities. An efficient and rapid pathological flow is fully supported.
By storing pathology image data and case information on the cloud, PidPort enables the secure management and rapid search of information. No need to install an application, just access PidPort on your PC or tablet. There is no need for initial costs such as equipment installation and you can use it anytime and anywhere in any environment where the Internet is available. We will reduce the workload of pathologists by creating a comfortable environment for pathological diagnoses at a low cost and promptly.
Introducing PidPort enables the easy sharing of diagnoses and cases anytime and anywhere. It comes standard with its own high-speed viewer with excellent visibility and operability, enabling smooth and comfortable pathological diagnoses on the cloud. Timely and smooth consultations between facilities is possible, leading to the resolution of problems that have previously required the transportation of pathological specimens and business trips to a remote location.
We have developed our own AI for a number of disorders that analyzes pathological image data immediately with high accuracy. Through collaborative research with multiple medical institutions, it creates digital images based on hundreds of thousands of pathological specimens. Furthermore, a large number of highly specialized pathologists create teacher data in order to develop pathological AI by deep learning/transfer learning of unique technology. We are willing to contribute to the development of AI in order to be a partner for pathologists so that it can eliminate their workloads and psychological burdens in the future.
By building a strong mutual support network with group hospitals and related hospitals around the world, we will make daily diagnostic work more comfortable and reduce the burden on pathologists in the field.
This allows you to create an environment where you can easily hold and participate in conferences from your homes and other remote locations.
Significant learning effects are expected by establishing an environment where you can learn and carefully observe all pathological diagnostic specimens on a virtual slide rather than learning by microscopic photography with a limited field of view.
Taking advantage of the characteristics of the cloud enables improvement in the efficiency and speed of collaborative research
It comes standard with our own high-speed viewer that is highly visible and user-friendly, with no need for soft installation, so you can use it comfortably.
Commenting on a case allows users to communicate with each other online. It can be used for a wide range of purposes such as consultations, academic meetings, educational research, etc.
A lot of drawing tools are available for you to graphically illustrate and write in images. Written annotations (notes) can be shared between users.
You can upload pathology images and case data all at once.
You can tag case folders and set favorites, so they will be searched and displayed all at once.
Documents related to cases can be attached. You can comprehensively view virtual slides and necessary materials.
You can adjust the color to your liking and save the color settings separately for both shared and private use.
It is possible to display up to four virtual slides at the same time. A synchronization mode is equipped that enables the operation of all images at the same time.
Screenshots make it easy to save the parts you want to keep.
Osamu Iizuka,CEO
An undergraduate of the Department of Medicine, Kyushu Univ. School of Medicine. Osamu has many experiences of developing software in Machine Learning, Deep Learning & Web. After working as a web-engineer in a startup, and winning first place at a pitch competition in Silicon Valley, he founded Medmain with a few members from Kyushu University.
Masayuki Tsuneki,Board of Director
He worked at a national university, Yale University, and National Cancer Center as a pathology researcher, a pathologist and an academic teacher. He had been working on research in molecular pathology, particularly related to carcinogenesis. He is eager to create a new technology that can provide objective diagnoses in the field of clinical pathology based on scientific evidence. With his professional knowledge of human pathology, his strength is in international academic research.
Katsumasa Niki,Outside Director
As the head of the investment division of the SoftBank Group Corp., until 2016, he was in charge of investment projects at various stages both in Japan and overseas. He has been involved in major M&A such as Vodafone K.K. and Sprint, as well as investments in foreign technology companies and start-ups, and serves on the board of directors at both international and domestic companies. He has also served as an investment committee member at several domestic and international VCs. He currently supports start-ups as an AI-focused incubator and a president and CEO of VC DEEPCORE.
Shigeo Nakano,Outside Director
After graduating from Keio University School of Medicine and Graduate School of the same university, he worked at University of Occupational and Environmental Health and the Pathology Department of Saga Medical University. After that, he was engaged in research on skin pathology diagnosis at the Dermatopathology Laboratory of Thomas Jefferson University in the United States. After returning to Japan, he established a medical institution specializing in pathological diagnosis, and is currently engaged in hospital management and pathological diagnosis as the chief of the Kanto Regional Headquarters of the Kamachi Group and the general manager of pathological diagnosis department. His specialty is dermatopathology.
Noriyoshi Fukushima, MD, Ph.D.
He is a distinguished pathologist who contributed to the establishment of the WHO digestive system tumor classification and the WHO cytopathology reporting system. With experience at the National Cancer Center (Japan), the University of Tokyo, and Johns Hopkins University (USA), he is currently Professor and Chair of the Department of Pathology at Jichi Medical University. In addition to his research activities, he founded "PathPort", an online community for pathologists, and is actively promoting collaboration to address the shortage of pathologists in Japan.
